Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1984-05-17 till 1984-10-22
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP Guideline study.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1984
Report date:
1984

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
other: French Guideline NF T 03.021 from 1980
Deviations:
no
GLP compliance:
yes
Test type:
standard acute method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
Methyl undec-10-enoate
EC Number:
203-910-8
EC Name:
Methyl undec-10-enoate
Cas Number:
111-81-9
Molecular formula:
C12H22O2
IUPAC Name:
methyl undec-10-enoate
Constituent 2
Reference substance name:
2023-910-8
IUPAC Name:
2023-910-8
Details on test material:
- Name of test material (as cited in study report): UNDECYLENATE DE METHYLE
- Substance type: organic
- Physical state: clear yellowish liquid
- Analytical purity: 98%
- Impurities (identity and concentrations): no data
- Purity test date: 24.02.84
- Lot/batch No.: UNDECYLENATE DE METHYLE, Analyse 151
- Expiration date of the lot/batch: no data
- Stability under test conditions: not reported
- Storage condition of test material: not reported
- Other:

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River France (76410, Saint Aubin les Elbeuf - France)
- Age: no data
- Weight at study initiation: 199g (males), 187g (females)
- Fasting period before study: no data
- Housing: 5 animals of same sex were housed in one polycarbonate cage with stainless top
- Diet (e.g. ad libitum): pelleted rat diet "Expanded SQC" (Special Diets Services Ltd, Witham, Essex, England)
- Water (e.g. ad libitum): potable water filtered through Millipore membrane, ad libitum
- Acclimation period: min. 7 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21°C ± 3°C
- Humidity (%): 50 % ± 20%
- Air changes (per hr): air was not recycled, air was filtered
- Photoperiod (hrs dark / hrs light): 12 h / 12 h

IN-LIFE DATES: From: 1984-05-17 To: 1984-07-31

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
unchanged (no vehicle)
Details on oral exposure:
VEHICLE: not applicable


MAXIMUM DOSE VOLUME APPLIED: 5.7 ml/kg


DOSAGE PREPARATION (if unusual):


CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose:
Doses:
620, 1240, 1860, 2570 mg/kg body weight (pre-test 5000 mg/ kg bw)
No. of animals per sex per dose:
10
Control animals:
yes
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: clinical observations frequently directly after test item application, and twice a day thereafter; body weight measurement just before test item application, and at days 4, 7, and 14
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight
Statistics:
no statistics applied

Results and discussion

Preliminary study:
5000 mg/kg bw: animals are in state of coma one hour after test item application.
Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
ca. 1 563 mg/kg bw
95% CL:
>= 1 225 - <= 1 875
Mortality:
Number and date of deaths at each dose:
At 620 mg/kg: no death
At 1240 mg/kg: 2 dead animals on day 1
At 1860 mg/kg: 8 dead animals 3 hours after treatment
At 2570 mg/kg: 9 dead animals 3 hours after treatment
Clinical signs:
other: At 620 mg/kg: no symptom At 1240 mg/kg: hypokinesia on day 1, then no symptom At 1860 mg/kg: hypokinesia and sedation on day 1, pilo-erection from D1 to D6, then no symptom. At 2570 mg/kg: sedation on day 1, then no symptom. One male went into a coma
Gross pathology:
Due to absence of any macroscopally visible lesions, no further histopathologic investigations
Other findings:
- Organ weights: no abnormalities reported
- Histopathology: not investigated (see above)
- Potential target organs: not investigated
- Other observations:

Applicant's summary and conclusion

Interpretation of results:
Toxicity Category IV
Remarks:
Migrated information Criteria used for interpretation of results: other: Guidance to regulation (EC) No 1272/2008 on CLP of substances and mixtures.
Conclusions:
LD50 is assessed at 1563 mg/kg (95% CL 1225-1875 mg/kg). Symptoms start to appear within 15 min after treatment at the dose of 1248 mg/kg and above (hypokinesia, sedation and coma). Mortality appears 3 hours after treatment, until day 1. Acc. to UN-GHS, the test item UNDECYLENATE DE METHYLE is classified as acute toxic (oral) category 4.
Executive summary:

LD50 is assessed at 1563 mg/kg (95% CL 1225-1875 mg/kg). Symptoms start to appear within 15 min after treatment at the dose of 1248 mg/kg and above (hypokinesia, sedation and coma). Mortality appears 3 hours after treatment, until day 1. Acc. to UN-GHS, the test item UNDECYLENATE DE METHYLE is classified as acute toxic (oral) category 4.